You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Isocitrate Dehydrogenase (IDH) Mutations

Showing 1 - 25 of 2,781
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Tumor, Cancer Trial run by the National Cancer Institute (NCI) (Zotiraciclib)

Not yet recruiting
  • Brain Tumor
  • Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Glioma, Malignant, Computer-Assisted Trial in Shanghai (Validation of IDH1 mutations from the radiomics model)

Active, not recruiting
  • Glioma, Malignant
  • Computer-Assisted
  • Validation of IDH1 mutations from the radiomics model
  • Shanghai, Shanghai, China
    Huashan Hospital, Fudan University
Jul 23, 2023

Isocitrate Dehydrogenase Gene Mutation Trial in Spain, United States (HMPL-306)

Recruiting
  • Isocitrate Dehydrogenase Gene Mutation
  • Atlanta, Georgia
  • +6 more
Feb 22, 2022

Isocitrate Dehydrogenase Gene Mutation Trial in Spain, United States (HMPL-306)

Recruiting
  • Isocitrate Dehydrogenase Gene Mutation
  • Santa Monica, California
  • +8 more
Feb 22, 2022

Leukemia, Myeloid, Acute Trial in Worldwide (AG-120, Azacitidine, AG-221)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Duarte, California
  • +72 more
Aug 18, 2022

Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype Trial in Calgary (Niacin CRT)

Recruiting
  • Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
  • Niacin CRT
  • Calgary, Alberta, Canada
    Tom Baker Cancer Centre
Jul 18, 2022

Glioma of Brain Trial in Bern, Lausanne, Zürich (L19TNF)

Active, not recruiting
  • Glioma of Brain
  • Bern, Switzerland
  • +2 more
Apr 7, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Biospecimen Collection
  • +2 more
  • Orange, California
  • +9 more
Jan 27, 2023

Epilepsy; Seizure Trial (ES-481)

Withdrawn
  • Epilepsy; Seizure
  • (no location specified)
Mar 28, 2022

Vascular Habitats Within Astrocytoma Grade 4 at Molecular,

Recruiting
  • Astrocytoma, Grade IV
  • +7 more
    • Valencia, Spain
      Biomedical Data Science Lab. Universitat Politècnica de València
    May 11, 2022

    Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme Trial in Cleveland (Eflornithine (Dose Level 1), Eflornithine

    Recruiting
    • Glioblastoma, IDH-wildtype
    • +4 more
    • Eflornithine (Dose Level 1)
    • +3 more
    • Cleveland, Ohio
      The Cleveland Clinic
    May 19, 2023

    Glioma Trial (AB-218)

    Not yet recruiting
    • Glioma
    • (no location specified)
    Mar 29, 2022

    Biliary Carcinoma Trial in China (TQB3454 tablets, TQB3454 tablets matching )

    Not yet recruiting
    • Biliary Carcinoma
    • TQB3454 tablets
    • TQB3454 tablets matching placebo
    • Beijing, Beijing, China
    • +5 more
    Aug 4, 2023

    Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Astrocytoma, Grade III Trial in San Antonio, Zuerich (Debio 0123,

    Not yet recruiting
    • Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
    • Astrocytoma, Grade III
    • Debio 0123
    • +2 more
    • San Antonio, Texas
    • +1 more
    Mar 9, 2023

    IDH Mutation, IDH1 Mutation, IDH2 Gene Mutation Trial in Chicago (Ivosidenib, Enasidenib, Fedratinib)

    Recruiting
    • IDH Mutation
    • +4 more
    • Chicago, Illinois
      University of Chicago Medical Center
    Nov 12, 2021

    Cholangiocarcinoma Trial in Boston (Dasatinib)

    Completed
    Has Results
    • Cholangiocarcinoma
    • Boston, Massachusetts
    • +1 more
    Jul 20, 2020

    Adult Gliomas, Mixed Trial in San Francisco (Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG), Magnetic Resonance Image

    Recruiting
    • Adult Gliomas, Mixed
    • Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG)
    • Magnetic Resonance Image (MRI)
    • San Francisco, California
      University of California, San Francisco
    May 9, 2023

    Recurrent Glioblastoma Multiforme (GBM), Grade 3 Isocitrate Dehydrogenase (IDH) Wildtype Astrocytoma, Grade 3 or 4 Astrocytoma

    Recruiting
    • Recurrent Glioblastoma Multiforme (GBM)
    • +3 more
    • Los Angeles, California
    • +4 more
    May 5, 2022

    Leukemia, Myeloid, Isocitrate Dehydrogenase Trial in Worldwide (AG-221, BSC, Azacitidine)

    Active, not recruiting
    • Leukemia, Myeloid
    • Isocitrate Dehydrogenase
    • Los Angeles, California
    • +145 more
    Jun 7, 2022

    Acute Myeloid Leukemia Trial in Columbus (Azacitidine, Biopsy, Enasidenib)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Jun 30, 2022

    Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Baltimore, Boston, Columbus (Enasidenib)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Chronic Myelomonocytic Leukemia
    • Baltimore, Maryland
    • +3 more
    Aug 8, 2022

    Glioma, Brain Tumor, Primary Brain Tumor Trial in Miami (3T MRI Scanner)

    Recruiting
    • Glioma
    • +4 more
    • 3T MRI Scanner
    • Miami, Florida
      University of Miami
    Mar 15, 2022

    Recurrent IDH1/2 Mutated Glioma Trial in Paris (Azacitidine)

    Recruiting
    • Recurrent IDH1/2 Mutated Glioma
    • Paris, France
      Pitie Salpetriere Hospital
    Aug 29, 2022

    Gliomas Trial in Miami, Boston, New York (Nivolumab)

    Active, not recruiting
    • Gliomas
    • Miami, Florida
    • +3 more
    May 5, 2022

    Glioma Trial in Paris (MRI)

    Not yet recruiting
    • Glioma
    • MRI
    • Paris, France
      Pitié-Salpetrière Hospital
    Jan 27, 2023